Duke University Health System has received the largest donation in its history—a monumental $50 million from an anonymous donor—to fund a cutting-edge proton beam therapy center. This transformational gift is a cornerstone in the development of the $120 million facility, expected to open in 2029, and is set to revolutionize cancer care in North Carolina and beyond.
“This is a historic gift for Duke and the state of North Carolina,” Duke University President Vincent Price announced. “The Duke Proton Center will make a significant impact on cancer care in our region, and we are very grateful for the generous support that has made this development possible.”
Proton therapy, known for its precision and reduced side effects, represents a breakthrough in cancer treatment. It targets tumors with a highly focused dose of radiation while sparing surrounding healthy tissues, making it especially effective for children and tumors located in sensitive areas like the brain, head, neck, and eyes.
Dr. Craig Albanese, CEO of Duke University Health System, emphasized the importance of this advancement, stating, “The addition of proton therapy to our clinical capabilities will make a huge difference in the lives of cancer patients across the region.”
The center will provide care for approximately 800 patients annually, with a focus on reducing side effects and improving quality of life. For example, brain tumor patients could experience less cognitive damage, and breast cancer patients may see less harm to heart function.
The facility will also bolster Duke’s position as a leader in medical physics and oncology research, enabling the development of new treatment protocols and clinical trials. “Proton therapy research and trials will advance cancer treatments and enhance Duke’s impact in many fields, including health care, research, and education,” said Dr. Mary Klotman, Duke’s senior vice president for health affairs.
Dr. Michael Kastan, executive director of the Duke Cancer Institute, described the technology as pivotal for cancers such as gliomas, meningiomas, and tumors at the base of the skull. He added, “Having proton therapy at Duke will enable us to push those boundaries, improve existing applications, and develop new ones through new clinical trials.”
The Duke Proton Center represents a bold step forward in cancer care, combining innovative technology, world-class research, and an unwavering commitment to improving patient outcomes. With this historic donation, Duke University Health System is set to become a leader in advanced cancer treatment, offering hope and healing to patients across the region.
